by The poultry vaccine market consists of vaccines administered to farmed birds such as chickens, turkeys, and ducks. These vaccines help prevent infectious and non-infectious diseases in poultry and curb significant economic losses. Key vaccines in the market include infectious bursal disease vaccine, Newcastle disease vaccine, avian influenza vaccine, and avian encephalomyelitis vaccine. For instance, infectious bursal disease vaccine aids in preventing infectious bursal disease or Gumboro disease in chickens. The disease can significantly impact poultry production globally.
The global poultry vaccine market is estimated to be valued at US$ 1900.4 Mn in 2023 and is expected to exhibit a CAGR of 4.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
Technological advancements in vaccine production is expected to drive growth of the poultry vaccine market over the forecast period. Growing research into recombinant and DNA vaccines is simplifying vaccine production and reducing production costs. For example, researchers are developing DNA vaccinations that trigger production of antibodies against infectious bursal disease virus. Such vaccines allow for mass production and reduce reliance on egg-based and cell-based traditional production methods. Additionally, advances in synthetic biology are aiding development of more effective and tailored vaccines. This helps prevent a wide range of poultry diseases and improves yields for poultry farmers. Furthermore, growing demand for poultry meat and eggs globally is also fueling preventive healthcare measures like vaccination in commercial flocks. Widespread vaccination programs ensure productivity and food security.
Segment Analysis
The global poultry vaccine market is dominated by the infectious bronchitis vaccine segment which holds around 35% of the total market share. This is because infectious bronchitis is one of the most widespread diseases for poultry across the globe. The disease impacts poultry significantly by reducing egg production and quality. Thus, poultry farmers and producers majority vaccinate their flocks against infectious bronchitis to reduce financial losses.
PEST Analysis
Political: The regulatory policies for vaccination of poultry vary across countries but majority have made it mandatory to vaccinate commercial flocks. This ensures adequate vaccine supply and prevents outbreaks.
Economic: High demand for poultry meat and eggs has fueled large scale commercial poultry farming globally. To optimize production and reduce mortality rates, farmers heavily rely on vaccination which is driving the market growth.
Social: Rising awareness about zoonotic diseases and their prevention through vaccination is positively impacting the social factor.
Technological: Key players are increasingly investing in R&D to develop thermostable and application friendly vaccines. They are also focusing on recombinant and DNA vaccine technologies for improved efficacy.
Key Takeaways
The global Poultry Vaccine Market Trends is expected to witness high growth during the forecast period due to rising incidence of zoonotic diseases. The global poultry vaccine market is estimated to be valued at US$ 1900.4 Mn in 2023 and is expected to exhibit a CAGR of 4.2% over the forecast period 2023 to 2030.
The Asia Pacific region dominates the market and is expected to grow at the fastest pace owing to large poultry farming in China and India. The global poultry vaccine market is dominated by the Asia Pacific region which accounts for around 40% of the total market share. This is attributed to large scale poultry farming and growing meat demand in countries like China and India. Chinese poultry producers aggressively vaccinate their flocks to prevent losses from epidemics and ensure stable production.
Key players operating in the poultry vaccine market are GlaxoSmithKline plc, AbbVie Inc., Merck & Co., Inc., Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche AG, Bristol-Myers Squibb Company, Johnson & Johnson Services, Inc., Cipla Inc., Aurobindo Pharma, and Gilead Sciences. Key players are focusing on technology advancements and capacity expansions to strengthen their market presence.
Key players operating in the poultry vaccine market are focusing on strategic collaborations to develop new formulations. For instance, Merck & Co. partnered with Ceva Sante Animale to develop thermostable vaccines against top poultry diseases. Major players are also enhancing their production facilities across Asia Pacific and South America to tap into the high growth opportunities in these regions.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
